Disposable Plastic Blood Bag Market  By Type of Bag (Blood Collection Bags, Blood Transfusion Bags) , By End User (Blood Banks, Hospitals, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

September 2024 | 260 pages | ID: DEEBDACA4700EN
Allied Market Research

US$ 2,655.00

E-mail Delivery (PDF), Online Subscription, Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Disposable Plastic Blood Bag Market

The disposable plastic blood bag market was valued at $265.9 million in 2023 and is projected to reach $431.7 million by 2033, growing at a CAGR of 5% from 2024 to 2033.

A disposable plastic blood bag is a transparent storage product made from polyvinyl chloride. It is a flexible, disposable system that comprises of several components, including the bag, a tube, a puncturable transfusion pot, and a clamp. It is preliminarily infused with several reagents that ensure the viability of blood. These reagents include citrate as anticoagulant, dextrose for metabolism of stored blood cells, adenine to improve the viability of cells, and phosphate to reduce the acidity. The bags are predominantly designed with a capacity to store 350 ml and 450 ml of blood.

Increase in blood donation activities due to rise in awareness among individuals regarding its importance has boosted the demand for disposable plastic blood bags, propelling the growth of the market. In addition, expansion of the healthcare sector with the opening of new healthcare facilities fuels the requirement for blood storage solutions, augmenting the market development. To enhance their efficacy, the development of disposable plastic blood bags with integrated safety features is trending in the market. Manufacturers are focusing on creating blood bags with self-sealing & needle-free ports and tamper-evident closures so that the integrity of stored blood samples is maintained.

However, the use of plastics in the formation of blood bags raises concerns pertaining to environmental impact, hampering the development of the market. Moreover, the presence of multiple participants results in fragmentation and high competition, restraining the market growth considerably. On the contrary, constant explorations to enhance the functionality and efficacy of disposable plastic blood bags are poised to open new avenues for the market growth in coming years. For instance, the incorporation of barcoding and tracking systems into the bag enhances the traceability of available blood groups. Through such innovative bags, the status & location of available blood groups in blood banks and hospitals is easily trackable in real time. This enhances operational efficiency of facilities and improves their inventory management.

Segment Review

The disposable plastic blood bag market is segmented into type of bag, end user, and region. On the basis of type of bag, the market is bifurcated into blood collection bags and blood transfusion bags. Depending on end user, it is divided into blood banks, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type of bag, the blood collection bags segment dominates the market share.

Depending on end user, the hospitals segment acquires a high share of the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players of the global disposable plastic blood bag market include Terumo Corporation, Fresenius Kabi AG, Grifols, S.A., Macopharma SA, Haemonetics Corporation, JMS Co. Ltd, HLL Lifecare Limited, Poly Medicure Ltd., SURU International Pvt. Ltd, and Advacare Pharma Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:
  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
Key Market Segments

By Type Of Bag
  • Blood Collection Bags
  • Blood Transfusion Bags
By End User
  • Blood Banks
  • Hospitals
  • Others
By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA
  • Key Market Players
  • Terumo Corporation
  • Fresenius Kabi AG
  • Grifols, S.A.
  • Macopharma SA
  • Haemonetics Corporation
  • JMS Co. Ltd
  • HLL Lifecare Limited
  • Poly Medicure Ltd.
  • SURU International Pvt. Ltd
  • Advacare Pharma Inc.
CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
  1.4.1. Primary Research
  1.4.2. Secondary Research
  1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
  3.2.1. Top Investment Pockets
  3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
  3.3.1. Bargaining Power of Suppliers
  3.3.2. Threat of New Entrants
  3.3.3. Threat of Substitutes
  3.3.4. Competitive Rivalry
  3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
  3.4.1. Drivers
  3.4.2. Restraints
  3.4.3. Opportunities

CHAPTER 4: DISPOSABLE PLASTIC BLOOD BAG MARKET, BY TYPE OF BAG

4.1. Market Overview
  4.1.1 Market Size and Forecast, By Type Of Bag
4.2. Blood Collection Bags
  4.2.1. Key Market Trends, Growth Factors and Opportunities
  4.2.2. Market Size and Forecast, By Region
  4.2.3. Market Share Analysis, By Country
4.3. Blood Transfusion Bags
  4.3.1. Key Market Trends, Growth Factors and Opportunities
  4.3.2. Market Size and Forecast, By Region
  4.3.3. Market Share Analysis, By Country

CHAPTER 5: DISPOSABLE PLASTIC BLOOD BAG MARKET, BY END USER

5.1. Market Overview
  5.1.1 Market Size and Forecast, By End User
5.2. Blood Banks
  5.2.1. Key Market Trends, Growth Factors and Opportunities
  5.2.2. Market Size and Forecast, By Region
  5.2.3. Market Share Analysis, By Country
5.3. Hospitals
  5.3.1. Key Market Trends, Growth Factors and Opportunities
  5.3.2. Market Size and Forecast, By Region
  5.3.3. Market Share Analysis, By Country
5.4. Others
  5.4.1. Key Market Trends, Growth Factors and Opportunities
  5.4.2. Market Size and Forecast, By Region
  5.4.3. Market Share Analysis, By Country

CHAPTER 6: DISPOSABLE PLASTIC BLOOD BAG MARKET, BY REGION

6.1. Market Overview
  6.1.1 Market Size and Forecast, By Region
6.2. North America
  6.2.1. Key Market Trends and Opportunities
  6.2.2. Market Size and Forecast, By Type Of Bag
  6.2.3. Market Size and Forecast, By End User
  6.2.4. Market Size and Forecast, By Country
  6.2.5. U.S. Disposable Plastic Blood Bag Market
    6.2.5.1. Market Size and Forecast, By Type Of Bag
    6.2.5.2. Market Size and Forecast, By End User
  6.2.6. Canada Disposable Plastic Blood Bag Market
    6.2.6.1. Market Size and Forecast, By Type Of Bag
    6.2.6.2. Market Size and Forecast, By End User
  6.2.7. Mexico Disposable Plastic Blood Bag Market
    6.2.7.1. Market Size and Forecast, By Type Of Bag
    6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
  6.3.1. Key Market Trends and Opportunities
  6.3.2. Market Size and Forecast, By Type Of Bag
  6.3.3. Market Size and Forecast, By End User
  6.3.4. Market Size and Forecast, By Country
  6.3.5. France Disposable Plastic Blood Bag Market
    6.3.5.1. Market Size and Forecast, By Type Of Bag
    6.3.5.2. Market Size and Forecast, By End User
  6.3.6. Germany Disposable Plastic Blood Bag Market
    6.3.6.1. Market Size and Forecast, By Type Of Bag
    6.3.6.2. Market Size and Forecast, By End User
  6.3.7. Italy Disposable Plastic Blood Bag Market
    6.3.7.1. Market Size and Forecast, By Type Of Bag
    6.3.7.2. Market Size and Forecast, By End User
  6.3.8. Spain Disposable Plastic Blood Bag Market
    6.3.8.1. Market Size and Forecast, By Type Of Bag
    6.3.8.2. Market Size and Forecast, By End User
  6.3.9. UK Disposable Plastic Blood Bag Market
    6.3.9.1. Market Size and Forecast, By Type Of Bag
    6.3.9.2. Market Size and Forecast, By End User
  6.3.10. Rest Of Europe Disposable Plastic Blood Bag Market
    6.3.10.1. Market Size and Forecast, By Type Of Bag
    6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
  6.4.1. Key Market Trends and Opportunities
  6.4.2. Market Size and Forecast, By Type Of Bag
  6.4.3. Market Size and Forecast, By End User
  6.4.4. Market Size and Forecast, By Country
  6.4.5. China Disposable Plastic Blood Bag Market
    6.4.5.1. Market Size and Forecast, By Type Of Bag
    6.4.5.2. Market Size and Forecast, By End User
  6.4.6. Japan Disposable Plastic Blood Bag Market
    6.4.6.1. Market Size and Forecast, By Type Of Bag
    6.4.6.2. Market Size and Forecast, By End User
  6.4.7. India Disposable Plastic Blood Bag Market
    6.4.7.1. Market Size and Forecast, By Type Of Bag
    6.4.7.2. Market Size and Forecast, By End User
  6.4.8. South Korea Disposable Plastic Blood Bag Market
    6.4.8.1. Market Size and Forecast, By Type Of Bag
    6.4.8.2. Market Size and Forecast, By End User
  6.4.9. Australia Disposable Plastic Blood Bag Market
    6.4.9.1. Market Size and Forecast, By Type Of Bag
    6.4.9.2. Market Size and Forecast, By End User
  6.4.10. Rest of Asia-Pacific Disposable Plastic Blood Bag Market
    6.4.10.1. Market Size and Forecast, By Type Of Bag
    6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
  6.5.1. Key Market Trends and Opportunities
  6.5.2. Market Size and Forecast, By Type Of Bag
  6.5.3. Market Size and Forecast, By End User
  6.5.4. Market Size and Forecast, By Country
  6.5.5. Brazil Disposable Plastic Blood Bag Market
    6.5.5.1. Market Size and Forecast, By Type Of Bag
    6.5.5.2. Market Size and Forecast, By End User
  6.5.6. South Africa Disposable Plastic Blood Bag Market
    6.5.6.1. Market Size and Forecast, By Type Of Bag
    6.5.6.2. Market Size and Forecast, By End User
  6.5.7. Saudi Arabia Disposable Plastic Blood Bag Market
    6.5.7.1. Market Size and Forecast, By Type Of Bag
    6.5.7.2. Market Size and Forecast, By End User
  6.5.8. Rest of LAMEA Disposable Plastic Blood Bag Market
    6.5.8.1. Market Size and Forecast, By Type Of Bag
    6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

8.1. Terumo Corporation
  8.1.1. Company Overview
  8.1.2. Key Executives
  8.1.3. Company Snapshot
  8.1.4. Operating Business Segments
  8.1.5. Product Portfolio
  8.1.6. Business Performance
  8.1.7. Key Strategic Moves and Developments
8.2. Fresenius Kabi AG
  8.2.1. Company Overview
  8.2.2. Key Executives
  8.2.3. Company Snapshot
  8.2.4. Operating Business Segments
  8.2.5. Product Portfolio
  8.2.6. Business Performance
  8.2.7. Key Strategic Moves and Developments
8.3. Grifols, S.A.
  8.3.1. Company Overview
  8.3.2. Key Executives
  8.3.3. Company Snapshot
  8.3.4. Operating Business Segments
  8.3.5. Product Portfolio
  8.3.6. Business Performance
  8.3.7. Key Strategic Moves and Developments
8.4. Macopharma SA
  8.4.1. Company Overview
  8.4.2. Key Executives
  8.4.3. Company Snapshot
  8.4.4. Operating Business Segments
  8.4.5. Product Portfolio
  8.4.6. Business Performance
  8.4.7. Key Strategic Moves and Developments
8.5. Haemonetics Corporation
  8.5.1. Company Overview
  8.5.2. Key Executives
  8.5.3. Company Snapshot
  8.5.4. Operating Business Segments
  8.5.5. Product Portfolio
  8.5.6. Business Performance
  8.5.7. Key Strategic Moves and Developments
8.6. JMS Co. Ltd
  8.6.1. Company Overview
  8.6.2. Key Executives
  8.6.3. Company Snapshot
  8.6.4. Operating Business Segments
  8.6.5. Product Portfolio
  8.6.6. Business Performance
  8.6.7. Key Strategic Moves and Developments
8.7. HLL Lifecare Limited
  8.7.1. Company Overview
  8.7.2. Key Executives
  8.7.3. Company Snapshot
  8.7.4. Operating Business Segments
  8.7.5. Product Portfolio
  8.7.6. Business Performance
  8.7.7. Key Strategic Moves and Developments
8.8. Poly Medicure Ltd.
  8.8.1. Company Overview
  8.8.2. Key Executives
  8.8.3. Company Snapshot
  8.8.4. Operating Business Segments
  8.8.5. Product Portfolio
  8.8.6. Business Performance
  8.8.7. Key Strategic Moves and Developments
8.9. SURU International Pvt. Ltd
  8.9.1. Company Overview
  8.9.2. Key Executives
  8.9.3. Company Snapshot
  8.9.4. Operating Business Segments
  8.9.5. Product Portfolio
  8.9.6. Business Performance
  8.9.7. Key Strategic Moves and Developments
8.10. Advacare Pharma Inc.
  8.10.1. Company Overview
  8.10.2. Key Executives
  8.10.3. Company Snapshot
  8.10.4. Operating Business Segments
  8.10.5. Product Portfolio
  8.10.6. Business Performance
  8.10.7. Key Strategic Moves and Developments


More Publications